insights_auto
Why is BOT up 25,00%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
0,010 A$
arrow_upward
+25,00%(+0,0020) 1D
17 նոյ, 16:10:06 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
0,01 A$
High
0,01 A$
Low
0,01 A$
Mkt. cap
24,86 մլն
Avg. vol.
10,87 մլն
Volume
10,30 մլն
52-wk high
0,15 A$
52-wk low
0,01 A$
EPS
-0,03 A$
Shares outstanding
2,76 մլրդ
No. of employees
11
Open
0,01 A$
High
0,01 A$
Low
0,01 A$
Mkt. cap
24,86 մլն
Avg. vol.
10,87 մլն
Volume
10,30 մլն
52-wk high
0,15 A$
52-wk low
0,01 A$
EPS
-0,03 A$
Shares outstanding
2,76 մլրդ
No. of employees
11
News stories
From web sources and news partners
Benzinga
·
34 րոպե առաջ
Stock Market Today: Dow Jones, S&P 500 Futures Fall Ahead of Nvidia's Q3 Earnings— CBRS, AMZN, RCAT in Focus
The Motley Fool
·
1 ժամ առաջ
Could the Vanguard S&P 500 ETF Set You Up for Life? Here's What History Says.
Trefis
·
2 ժամ առաջ
31 S&P 500 Stocks Just Made New 52-Week Highs
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd